Recent research has clearly demonstrated that inflammatory and immune mechanisms in the central nervous system play important roles in neuropathic pain.
8 In response to nervous system damage, infiltration of inflammatory cells and activation of resident immune cells lead to the production and secretion of an array of inflammatory mediators. These mediators cause neuroimmune activation and sensitization of primary afferent neurons, resulting in a hypersensitivity to pain.
8 In the case of MS, the pathophysiology of neuropathic pain is thought to involve any of a variety of factors: glial cell inflammatory immune mechanisms, plaques that disrupt the spinothalamic and quintothalamic pathways, acquired channelopathy in specific nerves, and abnormal impulses through motor axons.
2 Headache, particularly migraine, in patients with MS is believed to result from inflammatory lesions in the trigeminocervical complex, rostral brainstem, and periaqueductal gray matter.
9,10 A possible contributor to pain in patients with PD may be nigrostriatal damage leading to dysfunction of the control exerted by the basal ganglia on cerebral areas responsible for processing nociceptive input.
7,11